A new “Zhejiang Made” standard for Absorbable Hemostatic Particles, drafted by Singclean, has been approved by Zhejiang Provincial Brand Association and officially released lately, Qianjiang Evening News report. This standard specifies basic requirements, technical requirements, test methods, inspection rules, marking, labeling, packaging, storage and quality commitment for Absorbable Hemostatic Particles and it is applicable to Absorbable Hemostatic Particles made from plant starch.
Surgiclean® Absorbable Hemostatic Particles, honored as “Zhejiang High-Quality Manufactured Product” and “ Zhejiang Excellent Industrial Product”, was developed by Singclean after eight years of unremitting effort. It’s prepared with potato starch as raw materials using emulsification crosslinking technology. Hemostasis is successfully achieved within 3 minutes and degradation in the bodies initiates after hemostasis and finishes within 7 days.
More information about Surgiclean® Absorbable Hemostatic Particles
-
singclean | 2019-05-16
Headlining FIGO 2025: A Can’t-Miss Keynote by Prof. Osama Shawki, Presented by Singclean & KSMSingclean, in partnership with Kayan Al-Seha Medical (KSM), will debut at FIGO 2025 in Cape Town with a keynote lecture by renowned gynecologist Professor Osama Shawki. His session will spotlight innovations in hysteroscopy and adhesion prevention, showcasing Singclean’s commitment to advancing women’s healthcare worldwide. -
singclean | 2019-05-16
Singclean Draws Major Attention at ESCRS 2025 with Advanced Viscoelastic Solution for Ophthalmic SurgeryCOPENHAGEN, DENMARK – Hangzhou Singclean Medical Products Co., Ltd. made a strong impression at the 45th ESCRS Congress (European Society of Cataract and Refractive Surgeons), held September 12–16, 2025, at the Bella Center in Copenhagen. Recognized globally for its high professional standards and influence in ophthalmology, the congress gathered leading industry manufacturers, surgeons, and specialists from around the world. -
singclean | 2019-05-16
Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.
